title: Dialysis facility ownership and epoetin dosing in hemodialysis patients: a dialysis provider's perspective.
authors.affiliation: Fresenius Medical Care North America, Lexington, MA 02451, USA. Michael.Lazarus.MD@fmc-na.com
authors.forename: J Michael
authors.initials: JM
authors.lastname: Lazarus
authors.forename: Raymond M
authors.initials: RM
authors.lastname: Hakim
mesh_terms: D000554:Ambulatory Care Facilities; D000740:Anemia / Q000188:drug therapy; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage*; D006282:Health Personnel; D006397:Hematinics / Q000008:administration & dosage*; D006801:Humans; D010067:Ownership; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000592:standards*
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa